MGI Tech Partners with Asia Pathogen Genomics Initiative to Advance Pathogen Genomics for Public Health in Asia
SINGAPORE, June 11, 2025 /PRNewswire/ — MGI Tech Co., Ltd. ('MGI'), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and Asia Pathogen Genomics Initiative ('Asia PGI'), part of the Duke-NUS Centre for Outbreak Preparedness (COP), have recently announced collaboration aimed at enhancing pathogen genomics sequencing efforts across Asia. This collaboration underscores a shared commitment to supporting public health initiatives through advanced life science technology.
As part of this collaboration, MGI and Asia PGI will jointly democratize the pathogen genomics sequencing technology in Singapore and across Asia. The collaborative efforts will include hosting webinars to provide practical knowledge in pathogen genomics sequencing and delivering hands-on technical training to institutions and laboratories aimed at improving capacity development in pathogen detection.
In addition, MGI also announced the launch of the MGI APAC Pandemic Preparedness Program (PPP) to strengthen the capabilities of genomics institutions and laboratories in pathogen surveillance. In collaboration with Asia PGI, the PPP aims to broaden the scope of pathogen surveillance solutions available to partner countries. The program offers a differentiated and sustainable alternative, focusing on application-centric and workflow-driven solutions. For example, it supports the development of equitable, effective, relevant, and validated workflow solutions to address acute infectious diseases.
'At the Duke-NUS Centre for Outbreak Preparedness, we believe that equitable access to pathogen genomic sequencing is fundamental to strengthening health security across South and Southeast Asia,' said Paul Pronyk, Director of COP. 'By collaborating with industry partners such as MGI, we are committed to ensuring that all communities in our region benefit from the latest advances in pathogen genomics – enabling early detection, informed response and ultimately, a healthier future for all.'
'We are proud to partner with Asia PGI to accelerate the application of cutting-edge sequencing technology in pathogen genomics,' said Roy Tan, General Manager of MGI Asia Pacific. 'Pathogen control is a pressing challenge for many countries in Asia. This partnership aims to improve the accessibility of pathogen genomics, empowering researchers and public health professionals in their fight against infectious diseases.'
In response to the growing demand for rapid and precise detection of infectious diseases, MGI has developed a diverse array of comprehensive products for various applications, including metagenomic sequencing, targeted sequencing, and whole genome sequencing of pathogenic microorganisms. Looking ahead, MGI is committed to continuing its innovation, providing automated, convenient, and efficient core tools for pathogen identification, drug resistance analysis, and traceability.
For more information of PPP, please visit: https://en.mgitech.cn/Home/Applications/index/id/23.html
About the Duke-NUS Centre for Outbreak Preparedness (COP) and its Asia Pathogen Genomic Initiative (Asia PGI)
The Duke-NUS Centre for Outbreak Preparedness (COP) was established in 2022 to address the growing need for enhanced preparedness and response to infectious disease outbreaks in the Asian region. With a mission to bridge the gap between research, training, policy and practice, COP aims to enhance regional health security across South and Southeast Asia.
The Asia Pathogen Genomic Initiative (Asia PGI) is a flagship initiative of COP, aiming to harness scientific and technical partnerships across Singapore and Asia to advance genomic sequencing for infectious disease elimination.
For more information, please visit https://www.duke-nus.edu.sg/cop
About Duke-NUS Medical School
Duke-NUS is Singapore's flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted 'Clinicians Plus' poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five signature research programmes and 10 centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore's largest healthcare group. This strategic alliance has spawned 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives.
For more information, please visit www.duke-nus.edu.sg
About MGI
MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various other industries.
Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and establishing research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future.
For more information, please visit the MGI website or connect with us on Twitter, LinkedIn or YouTube.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
6 days ago
- The Star
IFC, gov't partner to strengthen Lao business environment
Laos aims to bring global best practices to the PPP tender process for projects such as hydropower dams. - Reuters VIENTIANE: The International Finance Corporation (IFC) is partnering with the government to improve the legal framework for Public-Private Partnerships (PPP), streamline investment entry and operational procedures, and enhance the overall business environment in Laos. This is aimed at advancing private sector investment in sectors that are critical to sustainable economic growth and job creation. Through a new collaboration with the Investment Promotion Department of the Ministry of Finance, the IFC, alongside the World Bank, will bring global best practices to the PPP tender process, increasing transparency and efficiency while providing capacity-building initiatives to equip government officials with practical experience in developing PPP projects. These efforts aim to attract private investment in key sectors such as agriculture, logistics, and green-related business activities, which are vital to Laos' sustainable development goals and job generation. By fostering private sector participation, the partnership will help create employment opportunities and strengthen the country's workforce. Laos offers substantial opportunities for investors. With its strategic location in Southeast Asia, a growing economy, and abundant natural resources, the government's recent initiatives to enhance cross-border connectivity and transform the country from land-locked to land-linked have further bolstered its investment appeal. Continued improvements in regulatory frameworks, institutional capacity, and market information will help unlock the full potential of private sector participation. Director General of the Investment Promotion Department, Dr Vanthana Nolintha, said 'Facilitating private investment is essential for driving economic growth and creating jobs in Laos. This partnership with the IFC will help us improve the legal framework for PPPs and streamline investment procedures, making it easier to do business in the country.' 'By leveraging IFC's expertise, we can ensure that our PPP projects are developed to international standards, creating a more conducive environment to attract private investment, especially foreign direct investment in strategic sectors.' The IFC's collaboration with the government builds on its ongoing support for reform efforts to improve the ease of doing business in Laos. By simplifying entry procedures and operational processes, the partnership aims to reduce barriers for investors, promote sustainable economic development, and generate employment opportunities. IFC Country Manager for Vietnam, Laos and Cambodia, Thomas Jacobs, said 'Private sector investment is a key engine of economic growth and creating a transparent and efficient business environment is critical to attracting investors.' 'Through this partnership, the IFC is committed to supporting Laos' reform agenda, helping the country unlock its private sector potential, and driving job creation in key industries.' Working in Laos since 1998, the IFC remains dedicated to supporting the country's development agenda by fostering private sector growth, promoting sustainability, and creating job opportunities. - Vientiane Times/ANN
Malaysian Reserve
11-06-2025
- Malaysian Reserve
MGI Tech Partners with Asia Pathogen Genomics Initiative to Advance Pathogen Genomics for Public Health in Asia
SINGAPORE, June 11, 2025 /PRNewswire/ — MGI Tech Co., Ltd. ('MGI'), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and Asia Pathogen Genomics Initiative ('Asia PGI'), part of the Duke-NUS Centre for Outbreak Preparedness (COP), have recently announced collaboration aimed at enhancing pathogen genomics sequencing efforts across Asia. This collaboration underscores a shared commitment to supporting public health initiatives through advanced life science technology. As part of this collaboration, MGI and Asia PGI will jointly democratize the pathogen genomics sequencing technology in Singapore and across Asia. The collaborative efforts will include hosting webinars to provide practical knowledge in pathogen genomics sequencing and delivering hands-on technical training to institutions and laboratories aimed at improving capacity development in pathogen detection. In addition, MGI also announced the launch of the MGI APAC Pandemic Preparedness Program (PPP) to strengthen the capabilities of genomics institutions and laboratories in pathogen surveillance. In collaboration with Asia PGI, the PPP aims to broaden the scope of pathogen surveillance solutions available to partner countries. The program offers a differentiated and sustainable alternative, focusing on application-centric and workflow-driven solutions. For example, it supports the development of equitable, effective, relevant, and validated workflow solutions to address acute infectious diseases. 'At the Duke-NUS Centre for Outbreak Preparedness, we believe that equitable access to pathogen genomic sequencing is fundamental to strengthening health security across South and Southeast Asia,' said Paul Pronyk, Director of COP. 'By collaborating with industry partners such as MGI, we are committed to ensuring that all communities in our region benefit from the latest advances in pathogen genomics – enabling early detection, informed response and ultimately, a healthier future for all.' 'We are proud to partner with Asia PGI to accelerate the application of cutting-edge sequencing technology in pathogen genomics,' said Roy Tan, General Manager of MGI Asia Pacific. 'Pathogen control is a pressing challenge for many countries in Asia. This partnership aims to improve the accessibility of pathogen genomics, empowering researchers and public health professionals in their fight against infectious diseases.' In response to the growing demand for rapid and precise detection of infectious diseases, MGI has developed a diverse array of comprehensive products for various applications, including metagenomic sequencing, targeted sequencing, and whole genome sequencing of pathogenic microorganisms. Looking ahead, MGI is committed to continuing its innovation, providing automated, convenient, and efficient core tools for pathogen identification, drug resistance analysis, and traceability. For more information of PPP, please visit: About the Duke-NUS Centre for Outbreak Preparedness (COP) and its Asia Pathogen Genomic Initiative (Asia PGI) The Duke-NUS Centre for Outbreak Preparedness (COP) was established in 2022 to address the growing need for enhanced preparedness and response to infectious disease outbreaks in the Asian region. With a mission to bridge the gap between research, training, policy and practice, COP aims to enhance regional health security across South and Southeast Asia. The Asia Pathogen Genomic Initiative (Asia PGI) is a flagship initiative of COP, aiming to harness scientific and technical partnerships across Singapore and Asia to advance genomic sequencing for infectious disease elimination. For more information, please visit About Duke-NUS Medical School Duke-NUS is Singapore's flagship graduate entry medical school, established in 2005 with a strategic, government-led partnership between two world-class institutions: Duke University School of Medicine and the National University of Singapore (NUS). Through an innovative curriculum, students at Duke-NUS are nurtured to become multi-faceted 'Clinicians Plus' poised to steer the healthcare and biomedical ecosystem in Singapore and beyond. A leader in ground-breaking research and translational innovation, Duke-NUS has gained international renown through its five signature research programmes and 10 centres. The enduring impact of its discoveries is amplified by its successful Academic Medicine partnership with Singapore Health Services (SingHealth), Singapore's largest healthcare group. This strategic alliance has spawned 15 Academic Clinical Programmes, which harness multi-disciplinary research and education to transform medicine and improve lives. For more information, please visit About MGI MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and establishing research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. For more information, please visit the MGI website or connect with us on Twitter, LinkedIn or YouTube.
New Straits Times
04-06-2025
- New Straits Times
Lee rode Korean voter discontent to power, now faces policy test
SOUTH Korea's new President Lee Jae-myung rode a wave of voter anger against the December martial law attempt by his ousted predecessor, but his ability to lead will be judged by the strength of his policies. With preliminary results suggesting a comfortable win over Kim Moon-soo, the candidate for the conservative People Power Party, Lee will take office with a resounding mandate and his Democratic Party in control of parliament. Healing the political rifts that led to former president Yoon Suk Yeol's shock martial law and its divisive aftermath will be a tall order. Analysts say both candidates were vague on their policy plans during the campaign, and Lee Jun-han, a political science professor at Incheon National University, said the results are more an indictment of Yoon and his PPP's poor performance than an endorsement of the DP. He said Kim, who opposed Yoon's impeachment, was unprepared and the PPP did not show remorse after the martial law. "(The next president) should properly interpret that the people's choice has been one-sided and show that in the government's operation or politics in the future," he said. "If they don't, public sentiment will fluctuate quickly." While Lee has had his eye on the presidency for years, there have been major developments since he narrowly lost to Yoon in the 2022 election, said Kim Jun-seok, a political science professor at Dongguk University. "Now he has restoration of democracy as one of his tasks," Kim said. "Nonetheless, there are huge challenges faced by South Korea. A grim outlook on the economy that's projected to grow maybe less than one per cent. "And there's a crisis outside, dealing with Trump. He has a lot of work to do." Voters said they were looking for the winner of the snap election to calm the economic and political shocks that have roiled the country since Yoon's Dec 3 martial law decree led to months of economic downturn and sparked nationwide protests. Many complained, however, about a lack of specifics in policy debates. Lee has pledged to draft a second supplementary budget for the year as soon as the election is over, and promised vouchers to help businesses and subsidies for childcare, youth, and the elderly to address growing discontent around tightening purse strings. His camp says they intend to seek more time to negotiate on trade with US President Donald Trump, but it is unclear how any request for an extension of the tariff deadline will be received in Washington. With a rise in anti-China sentiment among South Koreans and Trump's push to isolate Beijing, Lee must also tread carefully with any plans to improve ties with China. Lee has also shown sensitivity to the political winds, moderating some of his stances on China, Japan, and populist economic policies such as universal income ahead of the election. "I hope he will resuscitate the economy and get rid of insurrection forces," said Im Young-taek, 64, a small business owner. "And I do hope he will make people comfortable. "Things may not be easy with Trump, but I hope he will hire capable aides and settle the issues." Lee's Democratic Party will control Parliament, easing the passage of legislation and budgets after years of deadlock between Yoon and the legislature. That may do little to soothe political polarisation, however, with conservatives warning that Lee and the DP will steamroll over any opposition. Incheon University's Lee said: "Since they are the absolute majority, there seems to be few checks and balances to stop them." In May, a DP-led committee passed legislation aimed at changing an election law that Lee has been convicted of violating. They have also promised to pass legislation clarifying what protections presidents have from criminal investigations, a move seen as trying to reduce Lee's exposure to other charges.
